Dr. Rini on Axitinib for Treatment of Metastatic Renal Cell Carcinoma
October 19th 2015Brian Rini, MD, associate professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, discusses a phase Il study that examined axitinib as a second-line therapy for metastatic renal cell carcinoma.